The immune system in cancer metastasis: friend or foe?
暂无分享,去创建一个
C. Logsdon | W. Overwijk | Willem W. Overwijk | Louise M.E. Janssen | Emma E. Ramsay | Craig D. Logsdon | L. Janssen
[1] C. Galmarini,et al. Concomitant resistance and early-breast cancer: should we change treatment strategies? , 2013, Cancer and Metastasis Reviews.
[2] J. Oppenheim,et al. Alarmins and Antitumor Immunity. , 2016, Clinical therapeutics.
[3] H. Putter,et al. NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study , 2012, BMC Cancer.
[4] M. Miyazaki,et al. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer. , 2009, European journal of cancer.
[5] T. Hagemann,et al. Tumour-associated macrophages and cancer. , 2013, Current opinion in pharmacology.
[6] D. Xie,et al. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. , 2012, Cancer cell.
[7] J. Pollard,et al. Immune cell promotion of metastasis , 2015, Nature Reviews Immunology.
[8] J. Pollard,et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.
[9] J. Remack,et al. ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma , 2008, PloS one.
[10] R. Ruggiero,et al. A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours. , 1996, British Journal of Cancer.
[11] L. Lanier,et al. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] John M L Ebos,et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. , 2009, Cancer cell.
[13] E. Alici,et al. Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity , 2015, Front. Immunol..
[14] L. Zitvogel,et al. Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer , 2012, Oncoimmunology.
[15] T. Nomura,et al. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. , 2006, Current topics in microbiology and immunology.
[16] H. Friess,et al. Desmoplastic Reaction Influences Pancreatic Cancer Growth Behavior , 2004, World Journal of Surgery.
[17] W. Zou,et al. Regulatory T-cell compartmentalization and trafficking. , 2006, Blood.
[18] R. Azevedo,et al. T Cells Induce Pre-Metastatic Osteolytic Disease and Help Bone Metastases Establishment in a Mouse Model of Metastatic Breast Cancer , 2013, PloS one.
[19] Alexandre Corthay,et al. Does the Immune System Naturally Protect Against Cancer? , 2014, Front. Immunol..
[20] N. Mukaida,et al. High-dose cyclophosphamide induces specific tumor immunity with concomitant recruitment of LAMP1/CD107a-expressing CD4-positive T cells into tumor sites. , 2015, Cancer letters.
[21] I. Holen,et al. Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis , 2014, Bone.
[22] S. Karpatkin,et al. Role of Platelets, Thrombin, Integrin llb-llla, Fibronectin and Von Willebrand Factor on Tumor Adhesion in Vitro and Metastasis in Vivo , 1995, Thrombosis and Haemostasis.
[23] M. Yashiro,et al. ICAM-2 Gene Therapy for Peritoneal Dissemination of Scirrhous Gastric Carcinoma , 2004, Clinical Cancer Research.
[24] H. Komatsu. [Antibody therapy in cancer]. , 2010, Nihon rinsho. Japanese journal of clinical medicine.
[25] R. North,et al. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites , 1977, The Journal of experimental medicine.
[26] M. Shibuya,et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.
[27] R. Ruggiero,et al. Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases control. , 2012, Cancer research.
[28] M. Toda,et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.
[29] Lewis L Lanier,et al. Natural killer cells and cancer. , 2003, Advances in cancer research.
[30] Hongwei Liang,et al. Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance , 2014, Front. Immunol..
[31] Zhiwei Hu,et al. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. , 2007, Blood.
[32] L. Coussens,et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. , 2009, Cancer cell.
[33] I. Ellis,et al. Upregulation of MICA on high-grade invasive operable breast carcinoma. , 2007, Cancer immunity.
[34] E. Gorelik. Concomitant tumor immunity and the resistance to a second tumor challenge. , 1983, Advances in cancer research.
[35] Georg Krupitza,et al. Initial steps of metastasis: Cell invasion and endothelial transmigration , 2011, Mutation research.
[36] D. Bowtell,et al. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. , 2012, Cancer research.
[37] K. Steimer,et al. Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type 1 in chimpanzees infected with the virus and baboons immunized with a candidate recombinant vaccine. , 1992, The Journal of general virology.
[38] S. Briest,et al. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. , 2009, Cancer research.
[39] J. Peterse,et al. Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.
[40] R. Kerbel,et al. Mouse models of advanced spontaneous metastasis for experimental therapeutics , 2011, Nature Reviews Cancer.
[41] I. Mellman,et al. Oncology meets immunology: the cancer-immunity cycle. , 2013, Immunity.
[42] W. Schatten. An experimental study of postoperative tumor metastases. I. Growth of pulmonary metastases following total removal of primary leg tumor , 1958, Cancer.
[43] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[44] M. Liu,et al. Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors. , 1998, Cancer research.
[45] A. Möller,et al. Hypoxia-driven immunosuppression contributes to the pre-metastatic niche , 2013, Oncoimmunology.
[46] C. Janeway. Immunobiology: The Immune System in Health and Disease , 1996 .
[47] J. Erler,et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.
[48] Lucas H. Horan,et al. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. , 2014, The Journal of clinical investigation.
[49] G. Cheng,et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.
[50] M. A. Curotto de Lafaille,et al. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? , 2009, Immunity.
[51] E. E. Tyzzer. Factors in the Production and Growth of tumor Metastases. , 1913, The Journal of medical research.
[52] R. Weissleder,et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo , 2005 .
[53] A. Ben-Baruch. Organ selectivity in metastasis: regulation by chemokines and their receptors , 2007, Clinical & Experimental Metastasis.
[54] P. Dalerba,et al. Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction , 2002, Immunological reviews.
[55] George Coukos,et al. Cancer immunotherapy comes of age , 2011, Nature.
[56] Y. Kimura,et al. Resveratrol Prevents Tumor Growth and Metastasis by Inhibiting Lymphangiogenesis and M2 Macrophage Activation and Differentiation in Tumor-associated Macrophages , 2016, Nutrition and cancer.
[57] J. Schlom,et al. Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity , 2011, Experimental biology and medicine.
[58] S. Bu,et al. N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells , 2013, BMC Cancer.
[59] Cyrus M. Ghajar,et al. Circulating and disseminated tumor cells: harbingers or initiators of metastasis? , 2017, Molecular oncology.
[60] E. R. Kasala,et al. Natural killer cells: the journey from puzzles in biology to treatment of cancer. , 2015, Cancer letters.
[61] Benjamin G. Gowen,et al. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection , 2015, Science.
[62] H. Wiley,et al. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo , 2013, Oncogene.
[63] Wei Wu,et al. Tumor-derived CD4+CD25+ Tregs inhibit the maturation and antigen-presenting function of dendritic cells. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[64] J. Trowsdale,et al. ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients , 2010, International journal of cancer.
[65] S. Rosenberg,et al. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.
[66] C. Lewis,et al. Macrophage regulation of tumor responses to anticancer therapies. , 2013, Cancer cell.
[67] P. Reitsma,et al. Tissue factor associates with survival and regulates tumour progression in osteosarcoma , 2016, Thrombosis and Haemostasis.
[68] J. Blay,et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner , 2005, The Journal of experimental medicine.
[69] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.
[70] O. Joffre,et al. Cross-presentation by dendritic cells , 2012, Nature Reviews Immunology.
[71] R. Weissleder,et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[72] Z. Ballas,et al. Role of NK Cell Subsets in Organ-Specific Murine Melanoma Metastasis , 2013, PloS one.
[73] M. Smyth,et al. NKG2D function protects the host from tumor initiation , 2005, The Journal of experimental medicine.
[74] E. Dye. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells. , 1986, Journal of immunology.
[75] J. Berzofsky,et al. Selective Inhibition of Regulatory T Cells by Targeting the PI3K–Akt Pathway , 2014, Cancer Immunology Research.
[76] I. Ellis,et al. Expression of the stress‐related MHC class I chain‐related protein MICA is an indicator of good prognosis in colorectal cancer patients , 2006, International journal of cancer.
[77] R. Robison,et al. Macrophage Polarization and Its Role in Cancer , 2015 .
[78] R. Muschel,et al. Coagulation and metastasis: what does the experimental literature tell us? , 2013, British journal of haematology.
[79] Jinghang Zhang,et al. CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.
[80] I. Fidler,et al. Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .
[81] N. Kawashima,et al. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[82] M. Smyth,et al. Immune surveillance of tumors. , 2007, The Journal of clinical investigation.
[83] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[84] J. Sosman,et al. Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy , 2013, Cancer Immunology Research.
[85] Bethan Psaila,et al. The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.
[86] W. Gorczyca,et al. Complement C 5 a receptor facilitates cancer metastasis by altering T cell responses in the metastatic niche , 2014 .
[87] Y. Kawakami,et al. The mechanisms of cancer immunoescape and development of overcoming strategies , 2011, International journal of hematology.
[88] J. Pollard,et al. A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.
[89] I. Svane,et al. Increase of Circulating CD4+CD25highFoxp3+ Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2 , 2010, Journal of immunotherapy.
[90] F. Balkwill. The significance of cancer cell expression of the chemokine receptor CXCR4. , 2004, Seminars in cancer biology.
[91] Sharad K Sharma,et al. Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs , 2015, The Journal of Immunology.
[92] J. Bubeník. Tumour MHC class I downregulation and immunotherapy (Review). , 2003, Oncology reports.
[93] K. Arihiro,et al. FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients. , 2009, Oncology reports.
[94] K. Khazaie,et al. Regulation of COX2 Expression in Mouse Mammary Tumor Cells Controls Bone Metastasis and PGE2-Induction of Regulatory T Cell Migration , 2012, PloS one.
[95] E. Shevach. Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.
[96] R. Jain,et al. Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity. , 2011, Cancer cell.
[97] M. Bissell,et al. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. , 2006, Annual review of cell and developmental biology.
[98] Ruud H. Brakenhoff,et al. Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.
[99] T. Hembrough,et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. , 2003, Cancer research.
[100] Tom C. Freeman,et al. Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.
[101] J. Niederkorn,et al. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge. , 1983, Journal of immunology.
[102] C. Yee,et al. The Effect of Radiation on the Immune Response to Cancers , 2014, International journal of molecular sciences.
[103] J. Schlom,et al. Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination , 2011, Cancer Immunology, Immunotherapy.
[104] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[105] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[106] V. Vetvicka,et al. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18). , 1997, Journal of immunology.
[107] T. Schumacher,et al. T-cell-receptor gene therapy , 2002, Nature Reviews Immunology.
[108] S. Deodhar,et al. Role of preoperative irradiation in prolonging concomitant immunity and preventing metastasis in mice , 1971, Cancer.
[109] J. Degen,et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.
[110] J. Blay,et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. , 2016 .
[111] J. Abastado,et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. , 2010, The Journal of clinical investigation.
[112] Paul J Hertzog,et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape , 2012, Nature Medicine.
[113] A. Diefenbach,et al. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.
[114] R. Schreiber,et al. The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.
[115] A. Hesketh,et al. The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation , 2015, PloS one.
[116] M. Erkan. Understanding the stroma of pancreatic cancer: co‐evolution of the microenvironment with epithelial carcinogenesis , 2013, The Journal of pathology.
[117] J. Jonkers,et al. IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis , 2015, Nature.
[118] Tyzzer Ee,et al. Factors in the Production and Growth of tumor Metastases. , 1913 .
[119] A. Zlotnik. New insights on the role of CXCR4 in cancer metastasis , 2008, The Journal of pathology.
[120] A. Houghton,et al. Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells , 2004, The Journal of experimental medicine.
[121] G. Hill,et al. CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis , 2011, Proceedings of the National Academy of Sciences.
[122] A. Cerwenka,et al. NKG2D ligands in tumor immunity , 2008, Oncogene.
[123] A. Harris,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.
[124] C. Higano,et al. Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis. , 2013, The Journal of clinical investigation.
[125] J. Mann,et al. The role of pancreatic stellate cells in pancreatic cancer. , 2015, Surgical oncology.
[126] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[127] R. Ruggiero,et al. "Concomitant immunity" in murine tumours of non-detectable immunogenicity. , 1985, British Journal of Cancer.
[128] S. Quezada,et al. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies , 2009, The Journal of experimental medicine.
[129] J. Wolchok,et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma , 2013, The Journal of experimental medicine.
[130] S. Coffelt,et al. Systemic inflammation: Cancer's long-distance reach to maximize metastasis , 2016, Oncoimmunology.